跳至主要内容
临床试验/EUCTR2013-005371-40-PL
EUCTR2013-005371-40-PL进行中(未招募)不适用

Medical laser and stem cells in treatment ischemic heart disease

Szpital im. Jana Pawla II0 个研究点开始时间: 2014年7月2日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - End stage CHNS
  • - no possibility PCI or CABG
  • - Optimal medical therapy
  • - Symptoms (CCS III or IV)
  • - viability front and / or side wall of the myocardium
  • - EF> 30%
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 40
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • - Unstable ischemic heart disease,
  • - Acute myocardial infarction,
  • - Valvular heart disease,
  • - Heart defect congenital or acquired,
  • - EF <30%,
  • - Severe arrhythmias,
  • - Contraindications to general anesthesia,
  • - Contraindications to cardiac surgery,
  • - A disease in which life expectancy is less than 2 years,
  • - Peripheral vascular disease, restrictive normal functioning.,
  • - allergic for high-osmolar contrast media, claustrophobia

研究者

发起方
Szpital im. Jana Pawla II

相似试验

Stem cells in Heart disease | 临床试验